Search results
Results from the WOW.Com Content Network
Pupillary response is a physiological response that varies the size of the pupil between 1.5 mm and 8 mm, [1] via the optic and oculomotor cranial nerve. A constriction response ( miosis ), [ 2 ] is the narrowing of the pupil, which may be caused by scleral buckles or drugs such as opiates / opioids or anti-hypertension medications.
Non-physiological causes of mydriasis include disease, trauma, or the use of certain types of drugs. It may also be of unknown cause. It may also be of unknown cause. Normally, as part of the pupillary light reflex , the pupil dilates in the dark and constricts in the light to respectively improve vividity at night and to protect the retina ...
Weiss ring: a large, ring shaped floater that is sometimes seen if the vitreous body releases from the back of the eye. When this occurs there is a characteristic pattern of symptoms: Flashes of light ; A sudden dramatic increase in the number of floaters; A ring of floaters or hairs just to the temporal side of the central vision
Figure 1.0 - Basic anatomical features of the human eye. Ophthalmic drug administration is the administration of a drug to the eyes, most typically as an eye drop formulation. Topical formulations are used to combat a multitude of diseased states of the eye. These states may include bacterial infections, eye injury, glaucoma, and dry eye. [1]
Afferent signals from the left eye cannot pass through the transected left optic nerve to reach the intact efferent limb on the left. The right consensual reflex is lost. When left eye is stimulated by light, afferent signals from the left eye cannot pass through the transected left optic nerve to reach the intact efferent limb on the right.
Dilated fundus examination (DFE) is a diagnostic procedure that uses mydriatic eye drops to dilate or enlarge the pupil in order to obtain a better view of the fundus of the eye. [1] Once the pupil is dilated, examiners use ophthalmoscopy to view the eye's interior, which makes it easier to assess the retina , optic nerve head , blood vessels ...
Researchers have recently developed a new drug that will ultimately shrink down and dissolve cataracts -- the leading cause of human blindness that affects tens of millions of people worldwide. ...
It is commonly used as an eye drop during pediatric eye examinations to dilate the eye and prevent the eye from focusing/accommodating (cycloplegic). Cyclopentolate [citation needed] or atropine can also be administered to reverse muscarinic and central nervous system effects of indirect cholinomimetic (anti-AChase) administration.